Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingegerd Odar-Cederlöf

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Blood Pressure|March 18, 2005
Testing for microalbuminuria and albuminuria in diabetes should be as important as checking blood pressureThomas Leoo, Ingegerd Odar-Cederlöf
Clinical Nephrology|January 29, 2019
The importance of correct estimation of renal function for drug treatment in hospitalized elderly patients, especially women: A prospective observational study
Anders Helldén, Ulf Bergman, Ingegerd Odar-Cederlöf
Aging Clinical and Experimental Research|July 3, 2008
Renal function in community-dwelling frail elderly. Comparison between measured and predicted glomerular filtration rate in the elderly and proposal for a new cystatin C-based prediction equationAnna Törner, Ingegerd Odar-Cederlöf, Anders Kallner, et al.
Nephron Extra|December 10, 2015
Vasoactive Peptide Levels after Change of Dialysis ModeFredrik Uhlin, Ingegerd Odar-Cederlöf, Elvar Theodorsson, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|January 3, 2013
The effects of hemodialysis treatment on the level of DNA strand breaks and oxidative DNA lesions measured by the comet assayClara Ersson, Ingegerd Odar-Cederlöf, Ingela Fehrman-Ekholm, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 1, 2003
Neuropeptide-Y and atrial natriuretic peptide as prognostic markers in patients on hemodialysisIngegerd Odar-Cederlöf, Folke Ericsson, Elvar Theodorsson, et al.
BMJ (Clinical Research Ed.)|December 25, 2007
Death delusionAnders Helldén, Ingegerd Odar-Cederlöf, Kajsa Larsson, et al.
Lakartidningen|May 10, 2006
[Citalopram is not safe from the cardiac point of view--SSRI preparations can cause prolonged QTc time]Ingegerd Odar-Cederlöf, Peter Hjelmström, Ingela Jersenius, et al.
Scandinavian Journal of Urology and Nephrology|January 23, 2008
Concentrations of vitamin C, vitamin B12 and folic acid in patients treated with hemodialysis and on-line hemodiafiltration or hemofiltrationIngela Fehrman-Ekholm, Agneta Lotsander, Katarina Logan, et al.
European Journal of Clinical Pharmacology|June 19, 2012
Pharmacokinetics of transdermal buprenorphine patch in the elderlyNabil Al-Tawil, Ingegerd Odar-Cederlöf, Anna-Carin Berggren, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Blood Pressure|March 18, 2005
Testing for microalbuminuria and albuminuria in diabetes should be as important as checking blood pressureThomas Leoo, Ingegerd Odar-Cederlöf
Clinical Nephrology|January 29, 2019
The importance of correct estimation of renal function for drug treatment in hospitalized elderly patients, especially women: A prospective observational study
Anders Helldén, Ulf Bergman, Ingegerd Odar-Cederlöf
Aging Clinical and Experimental Research|July 3, 2008
Renal function in community-dwelling frail elderly. Comparison between measured and predicted glomerular filtration rate in the elderly and proposal for a new cystatin C-based prediction equationAnna Törner, Ingegerd Odar-Cederlöf, Anders Kallner, et al.
Nephron Extra|December 10, 2015
Vasoactive Peptide Levels after Change of Dialysis ModeFredrik Uhlin, Ingegerd Odar-Cederlöf, Elvar Theodorsson, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|January 3, 2013
The effects of hemodialysis treatment on the level of DNA strand breaks and oxidative DNA lesions measured by the comet assayClara Ersson, Ingegerd Odar-Cederlöf, Ingela Fehrman-Ekholm, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 1, 2003
Neuropeptide-Y and atrial natriuretic peptide as prognostic markers in patients on hemodialysisIngegerd Odar-Cederlöf, Folke Ericsson, Elvar Theodorsson, et al.
BMJ (Clinical Research Ed.)|December 25, 2007
Death delusionAnders Helldén, Ingegerd Odar-Cederlöf, Kajsa Larsson, et al.
Lakartidningen|May 10, 2006
[Citalopram is not safe from the cardiac point of view--SSRI preparations can cause prolonged QTc time]Ingegerd Odar-Cederlöf, Peter Hjelmström, Ingela Jersenius, et al.
Scandinavian Journal of Urology and Nephrology|January 23, 2008
Concentrations of vitamin C, vitamin B12 and folic acid in patients treated with hemodialysis and on-line hemodiafiltration or hemofiltrationIngela Fehrman-Ekholm, Agneta Lotsander, Katarina Logan, et al.
European Journal of Clinical Pharmacology|June 19, 2012
Pharmacokinetics of transdermal buprenorphine patch in the elderlyNabil Al-Tawil, Ingegerd Odar-Cederlöf, Anna-Carin Berggren, et al.
Pageof 3